Bio-Science Law Review reports and analyses these developments and acts as a forum for discussion of the legal protection and approval of these new technologies

Practical snazzy information for lawyers advising
bio-science and
bio-technology enterprises:
The rapid advances in bio-science and bio-technology have
resulted in a wealth of dynamic new industries and promise
great advances in medical therapies and related benefits. However, the underlying science that forms the basis of
developments in genomics, gene therapy and related areas
also poses new problems for both the regulatory and
traditional intellectual property rights systems. The
complex balance between rewarding the inventor and
investor, while at the same time not shutting out fair
competition, has been highlighted in a series of recent
cases. Bio-Science Law Review reports and analyses these
developments and acts as a forum for discussion of the
legal protection and approval of these new technologies. Bio-Science Law Review covers three main areas: * The management, protection and exploitation of
Intellectual Property Rights. * Licensing and approval of bio-tech / bio-science based
products. * General legal issues that affect the bio-tech / bio-science
industries. Each issue has two parts - an editorial section containing
an open editorial, articles, commentaries on specific cases
or legislation, letters and book reviews; and a news section
carrying national reports, as well as reports on the
activities of international and regional institutions (WIPO,
EPO, European Commission, ECJ) by our worldwide
contributors. Regular coverage on developments in patent
law and practice, joint ventures and other forms of
collaboration, the legal issues of raising finance for bio-
science industries, competition law issues, trade mark
developments and reports on the activities of regulatory
agencies such as the EMEA and FDA. Editorial Advisory Board: Nicholas A Carter, Solicitor, London;
Professor Gerald Dworkin, Emeritus Professor of Law, Kings;
College London;
Richard Hacon, Barrister, London;
Nigel Jones, Linklaters & Paines, London;
Tim Roberts, Roberts & Co, London;
Nick Scot Ram, Quercus Management.